Popular Articles
Cellulite Cream

WHO Raises Pandemic Alert To Phase 6, Director General Gives Speech
The World Health Organization (WHO) announced it has raised the level of influenza pandemic alert from phase 5 to phase 6, following an
generic viagra online
Pitt Researchers Find Promising Candidate Protein For Cancer Prevention Vaccines
Researchers at the University of Pittsburgh School of Medicine have learned that some healthy people naturally developed an immune response against a protein that is made in excess levels in many cancers, including breast, lung, and head and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in high-risk individuals.
News of the day
General Optical Council Highlights Importance Of Student Supervision, UK
The General Optical Council (GOC) is today reminding all optical businesses, students and supervisors to ensure their current arrangements for professional supervision of students meet the requirements outlined by the GOC, and examination or assessment bodies. This follows the recent Fitness to Practise (FTP) hearing involving Boots Opticians Ltd (a GOC-registered business); Trevor Burgess, a registered student dispensing optician; and Richard Simmons, a registered dispensing optician.
Public Health

Confirmed Link Between Chronic Infection And Immune-System Protein

The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body"s defense system. Researchers at the University of Alabama at Birmingham (UAB) have discovered that a key immunity protein must be present for this defense system to have a chance against chronic infection. Research up to now has tried but failed to decipher the cross-talk between "killer T-cells" and "helper T-cells" in the fight against viruses. The new UAB study finds this cross-talk can only happen in the presence of interleukin-21, a powerful immune system protein. If interleukin-21 is missing for whatever reason, then the immune system"s anti-viral efforts fail, said Allan Zajac, Ph.D., an associate professor in UAB"s Department of Microbiology and lead author on the study. The findings are published in the journal Science through its Science Express service. "Adding interleukin-21 back in stimulates the immune response and controls the infection," Zajac said. "We demonstrate that the loss of this protein prevents the control of the infection and diminishes the function of the killer T-cells, specifically CD8 T-cells." The study mice were treated for lymphocytic choriomeningitis, a viral infection of the membranes surrounding the brain and spinal cord. Measurements were taken for two types of T-cells, CD4 and CD8 T-cells, before and after the mice were treated with interleukin-21. "Interleukin-21 served as the key messenger between the T-cells, whereas before we didn"t know exactly how the two types of cells communicated with each other," Zajac said. The CD4 T-cells help the immune system do its job by boosting CD8 T-cells" ability to fight and kill viruses. Co-authors on the study include John Yi and Ming Du, Ph.D., both of UAB"s Department of Microbiology. Research funds came from the National Institutes of Health. Troy Goodman University of Alabama at Birmingham


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):